Linvoseltamab
Regeneron
['linvoseltamab', 'linker-mm1', 'mmsm', 'linker,mm,3']
aa16: linker-mm1 study: linvoseltamab in rrmm:
- phase ii: single arm
- another bcma bite
- two cohorts: will focus on 200 mg cohort
- n= 117
- high risk cyto: 35%
- emd:14%
- lot:5
- triple/penta rrmm: 74%/24% #mmsm #myeloma #medtwitter #meded #asco23 #usmirc 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter